Bayer picks up Teva’s animal health biz for $145M

Pet project: Bayer deal comes day after Perrigo says it is buying Seargent’s By Eric Palmer In the second animal health deal announced in two days, generic drug giant Teva ...

More generics of J&J’s ADHD med Concerta coming

By Eric Palmer Johnson & Johnson ($JNJ) continues to cut generics deals over its onetime blockbuster Concerta, as it does what it can to protect sales of the attention-deficit ...

Boehringer Ingelheim lets Facebook game loose

By Eric Palmer Well it’s live, the Facebook game everyone has been waiting for. Well, at least some people in the pharmaceutical business. It is called “Syrum,” ...

U.S. consumers buy more, pay more for drugs

Lipid regulators, antidepressant sales say much about U.S. health By Eric Palmer U.S. patients took more drugs and paid more for drugs last year and, according to a new analysis, that ...

Feds win guilty pleas from two men in stem cell therapy scam

By Ryan McBride Two men pleaded guilty to crimes stemming from their scam to peddle unapproved stem cell treatments to patients with incurable neurological illnesses, a victory for ...

NJ biotech wins $14.5M from U.S. gov’t to study drug against anthrax

By Ryan McBride Uncle Sam has ponied up another $14.5 million in funding to advance Elusys Therapeutics‘ experimental drug for treating patients after anthrax attacks, according ...

Zambon, Italian pharma partner clash over CNS deal

By Ryan McBride Newron Pharmaceuticals appears to have miffed its largest shareholder, the Italy-based drugmaker Zambon, which takes issue with the terms and wisdom of Newron’s ...

Pharma counts just 3 Alzheimer’s drug wins in 13 years (101 losses!)

By Ryan McBride Alzheimer’s drug research has riddled biopharma with some of the worst odds of success in the already risky R&D game. And as the industry feels the sting ...

Massachusetts tops in U.S. for growth in biotech research jobs

By Ryan McBride Massachusetts‘ biotech industry group touted the growth of high-paying biotech jobs in the Bay State in 2011 as the commonwealth raised its profile further as ...

BioFire Dx adding hundreds of jobs in multi-million dollar expansion

By Damian Garde BioFire Diagnostics–formerly Idaho Technology–is using a $25 million tax credit from the state of Utah to expand its operations there, planning to add up ...

U.K. engineers target developing world with ultra-cheap ultrasound

By Damian Garde Engineers at the U.K.’s Newcastle University have developed an ultrasound scanner that costs £40 (about $65) to produce, and they’re looking for commercial ...

GE Healthcare, U. Wisconsin, seal $33M Dx partnership

By Mark Hollmer GE Healthcare ($GE) will invest nearly $33 million as part of a multi-faceted deal with the University of Wisconsin (UW) to boost collaboration on new imaging and ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS